MMA
IDXX icon

Miracle Mile Advisors’s Idexx Laboratories IDXX Stock Holding History

Miracle Mile Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
912
+148
+19% +$83K 0.01% 635
2026
Q1 		$430K Sell
764
-10
-1% -$6.41K 0.01% 621
2025
Q4 		$524K Buy
774
+56
+8% +$38.1K 0.01% 550
2025
Q3 		$459K Buy
718
+55
+8% +$33.4K 0.01% 569
2025
Q2 		$356K Buy
663
+113
+21% +$54K 0.01% 562
2025
Q1 		$231K Buy
550
+63
+13% +$27.4K ﹤0.01% 575
2024
Q4 		$201K Buy
+487
New +$214K ﹤0.01% 604

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Miracle Mile Advisors's IDXX Position: Q2 2026 in Review

Miracle Mile Advisors increased its Idexx Laboratories (IDXX) stake by 19% in Q2 2026, buying an estimated $83K and bringing the position to 912 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #635.

Miracle Mile Advisors first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $524K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Miracle Mile Advisors held 912 shares of Idexx Laboratories worth $480K as of Q2 2026.
  • Miracle Mile Advisors bought 148 Idexx Laboratories shares in Q2 2026, an estimated $83K.
  • Idexx Laboratories made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #635 holding.
  • Miracle Mile Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Miracle Mile Advisors's Idexx Laboratories position peaked at $524K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.